Victoria Meyer

Featured in: Favicon

mankatofreepress.com Favicon

pharmaceuticalonline.com Favicon

bioprocessonline.com Favicon

ondrugdelivery.com Favicon

biosimilardevelopment.com Favicon

outsourcedpharma.com Favicon

drugdeliveryleader.com

Articles

05.16.24 -- You Want To Rein In China? Then Actually Do It

May 16, 2024 | outsourcedpharma.com | Louis Garguilo |Mark Witcher |Mel Palmer |Victoria Meyer

Emerging biotherapies are enabling transition from traditional intravenous therapies to subcutaneous administration. The formulation of some biotherapies may present delivery challenges, such as larger volumes and viscosities that require innovative, patient-friendly delivery system design.
05.09.24 -- Sandoz, Amgen Resolve Denosumab Patent Litigation

May 9, 2024 | biosimilardevelopment.com | Matthew Pillar |Alex Santos |Geoff Middleton |Victoria Meyer

Get more biosimilar development insight with our FREE newsletter Newsletter | May 9, 2024 Webinar: Key Elements of Process and Analytical Development to Support Biologics Tech TransferJoin us on May 13th as our expert panel discusses the intricacies of technology transfer, drawing from real-life case studies. Investigate critical components for success, risk assessment, and effective mitigation strategies.
04.25.24 -- How Continuous Manufacturing Is Shaping Biopharma

Apr 25, 2024 | biosimilardevelopment.com | K. Coleman |Erich Bozenhardt |Victoria Meyer |P. Bhendale

Get more biosimilar development insight with our FREE newsletter Newsletter | April 25, 2024 Webinar: Key Elements of Process and Analytical Development to Support Biologics Tech TransferJoin us on May 13th as our expert panel discusses the intricacies of technology transfer, drawing from real-life case studies. Investigate critical components for success, risk assessment, and effective mitigation strategies.
09.21.23 -- De-Risking Biosimilar Development With A Clinically Validated And Commercially Proven Disposable Autoinjector

Sep 21, 2023 | biosimilardevelopment.com | Fran DeGrazio |Aditi Shivarkar |Victoria Meyer

Get more biosimilar development insight with our FREE newsletter Newsletter | September 21, 2023 The FDA now defines a prefilled syringe, a product that was at one point considered “packaging” for a drug, as a constituent part of a combination product.
05.25.23 -- All You Need To Know About Contamination Control Strategies, Part 1

May 25, 2023 | pharmaceuticalonline.com | Victoria Meyer |Joe Hoff |Oliver Stauffer |Grant Merrill

A conversation with Vanessa Figueroa, Rebecca Brewer, and Greg Gibb, Quality Executive Partners In the first of this two-part series, microbiology and contamination control specialists Vanessa Figueroa, Rebecca Brewer, and Greg Gibb, Ph.D., discuss best practices in developing contamination control strategies through the lens of the newly formalized provisions in the EU GMP Annex I, .